David Fallace
Listed on 2 Form D filings across 2+ issuers
· Director, Executive Officer
Associated issuers
- Cure Ventures Fund II, L.P. CIK 2094337 · MA
- Tasca Therapeutics Corp CIK 2046762 · MA
Filings (2)
-
Cure Ventures Fund II, L.P.D · 2025-12-18 · MA · Pooled Investment Fund
-
Tasca Therapeutics CorpD · 2025-12-01 · MA · Biotechnology$70.2Mview →